Tata Chemicals (TATACHEM) | Financial Analysis & Statements
Tata Chemicals Ltd. Mid-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
37.2B
Gross Profit
25.3B
68.11%
Operating Income
3.7B
9.92%
Net Income
3.2B
8.50%
EPS (Diluted)
₹9.89
Balance Sheet Metrics
Total Assets
377.8B
Total Liabilities
152.8B
Shareholders Equity
225.0B
Debt to Equity
0.68
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Tata Chemicals Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 147.8B | 153.0B | 166.8B | 125.2B | 100.9B |
| Cost of Goods Sold | 36.8B | 35.8B | 41.5B | 32.9B | 29.6B |
| Gross Profit | 111.0B | 117.2B | 125.3B | 92.3B | 71.3B |
| Gross Margin % | 75.1% | 76.6% | 75.1% | 73.7% | 70.7% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 32.8B | 27.9B | 27.5B | 22.9B | 18.3B |
| Other Operating Expenses | 39.1B | 42.3B | 42.6B | 31.1B | 24.2B |
| Total Operating Expenses | 71.9B | 70.1B | 70.1B | 54.0B | 42.5B |
| Operating Income | 8.3B | 19.4B | 29.9B | 15.4B | 7.7B |
| Operating Margin % | 5.6% | 12.7% | 17.9% | 12.3% | 7.6% |
| Non-Operating Items | |||||
| Interest Income | 450.0M | 1.4B | 750.0M | 1.2B | 747.6M |
| Interest Expense | 4.7B | 4.3B | 3.2B | 2.3B | 2.9B |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 5.2B | 8.3B | 27.4B | 16.7B | 6.3B |
| Income Tax | 1.7B | 3.8B | 2.9B | 2.7B | 2.0B |
| Effective Tax Rate % | 32.1% | 45.9% | 10.5% | 16.0% | 31.2% |
| Net Income | 3.9B | 4.4B | 24.3B | 14.0B | 4.4B |
| Net Margin % | 2.6% | 2.8% | 14.6% | 11.2% | 4.3% |
| Key Metrics | |||||
| EBITDA | 21.9B | 30.7B | 39.2B | 26.7B | 16.1B |
| EPS (Basic) | ₹9.23 | ₹10.52 | ₹90.95 | ₹49.37 | ₹10.06 |
| EPS (Diluted) | ₹9.23 | ₹10.52 | ₹90.95 | ₹49.37 | ₹10.06 |
| Basic Shares Outstanding | 254756278 | 254756278 | 254756278 | 254756278 | 254756278 |
| Diluted Shares Outstanding | 254756278 | 254756278 | 254756278 | 254756278 | 254756278 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Tata Chemicals Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 5.5B | 4.2B | 5.1B | 7.6B | 6.9B |
| Short-term Investments | 8.5B | 8.2B | 14.1B | 18.5B | 22.7B |
| Accounts Receivable | 19.0B | 19.0B | 26.3B | 19.3B | 14.0B |
| Inventory | 25.6B | 25.2B | 25.3B | 22.9B | 16.9B |
| Other Current Assets | 780.0M | 1.2B | 2.6B | 2.9B | 557.5M |
| Total Current Assets | 67.2B | 63.7B | 81.6B | 87.4B | 66.5B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 4.3B | 3.8B | 3.5B | 3.2B | 2.9B |
| Goodwill | 130.4B | 127.9B | 126.8B | 118.8B | 115.8B |
| Intangible Assets | 85.4B | 84.1B | 83.8B | 78.5B | 76.6B |
| Long-term Investments | 10.0M | 10.0M | 80.0M | 30.0M | 180.2M |
| Other Non-Current Assets | 230.0M | 220.0M | 180.0M | 180.0M | 124.9M |
| Total Non-Current Assets | 310.6B | 303.9B | 269.2B | 251.0B | 216.9B |
| Total Assets | 377.8B | 367.6B | 350.8B | 338.4B | 283.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 25.1B | 23.7B | 26.0B | 24.4B | 16.8B |
| Short-term Debt | 22.6B | 22.7B | 6.2B | 31.6B | 15.4B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 560.0M | 190.0M | 370.0M | 210.0M | 120.9M |
| Total Current Liabilities | 61.4B | 60.6B | 49.0B | 71.0B | 44.6B |
| Non-Current Liabilities | |||||
| Long-term Debt | 48.2B | 32.9B | 56.8B | 38.6B | 53.9B |
| Deferred Tax Liabilities | 25.4B | 23.8B | 19.4B | 20.4B | 15.7B |
| Other Non-Current Liabilities | 600.0M | 590.0M | 600.0M | 300.0M | 321.7M |
| Total Non-Current Liabilities | 91.4B | 75.9B | 95.4B | 75.9B | 87.3B |
| Total Liabilities | 152.8B | 136.4B | 144.4B | 146.9B | 131.9B |
| Equity | |||||
| Common Stock | 2.6B | 2.6B | 2.6B | 2.6B | 2.5B |
| Retained Earnings | 92.8B | 92.6B | 95.8B | 76.2B | 62.5B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 225.0B | 231.1B | 206.4B | 191.6B | 151.4B |
| Key Metrics | |||||
| Total Debt | 70.7B | 55.6B | 63.0B | 70.2B | 69.3B |
| Working Capital | 5.8B | 3.1B | 32.6B | 16.5B | 21.8B |
Balance Sheet Composition
Tata Chemicals Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 5.7B | 8.2B | 27.2B | 16.8B | 6.3B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -1.3B | 7.9B | -7.5B | -14.9B | 3.0B |
| Operating Cash Flow | 11.3B | 19.1B | 23.5B | 4.5B | 13.4B |
| Investing Activities | |||||
| Capital Expenditures | -19.5B | -18.2B | -15.4B | -12.6B | -12.3B |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -50.6B | -38.3B | -46.7B | -50.6B | -41.2B |
| Investment Sales | 49.2B | 45.3B | 47.9B | 52.2B | 40.2B |
| Investing Cash Flow | -19.4B | -11.8B | -10.4B | -9.3B | -12.3B |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -3.8B | -4.5B | -3.2B | -2.6B | -2.8B |
| Debt Issuance | 37.5B | 19.6B | 38.9B | 29.9B | 42.4B |
| Debt Repayment | -26.9B | -31.1B | -50.9B | -30.3B | -48.7B |
| Financing Cash Flow | 19.3B | -18.0B | -15.1B | -2.9B | -9.1B |
| Free Cash Flow | -2.4B | 11.8B | 13.9B | 3.7B | 8.0B |
| Net Change in Cash | 11.3B | -10.8B | -2.1B | -7.7B | -8.1B |
Cash Flow Trend
Tata Chemicals Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
108.83
Forward P/E
26.00
Price to Book
0.79
Price to Sales
1.21
PEG Ratio
-0.74
Profitability Ratios
Profit Margin
1.23%
Operating Margin
1.47%
Return on Equity
1.04%
Return on Assets
0.62%
Financial Health
Current Ratio
1.09
Debt to Equity
32.13
Beta
0.30
Per Share Data
EPS (TTM)
₹6.37
Book Value per Share
₹876.78
Revenue per Share
₹575.24
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| TATACHEM | 176.6B | 108.83 | 0.79 | 1.04% | 1.23% | 32.13 |
| Navin Fluorine | 322.4B | 57.84 | 8.89 | 10.99% | 17.74% | 32.68 |
| Deepak Nitrite | 230.5B | 43.19 | 4.18 | 12.85% | 6.71% | 22.41 |
| Deepak Fertilisers | 158.4B | 18.07 | 2.43 | 14.93% | 7.84% | 62.05 |
| Archean Chemical | 73.7B | 50.29 | 3.87 | 8.70% | 13.01% | 14.78 |
| Gujarat Narmada | 68.8B | 11.03 | 0.80 | 6.97% | 8.19% | 0.15 |
Financial data is updated regularly. All figures are in the company's reporting currency.





